The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
KR

k.radich

TL2 Moderator · Graz

Contributes reviews on supplier material. Based in Graz.

Joined 14 November 2024 · last posted 3d

89Posts here
3Topics
0Solutions
2kLikes received
1.1kLikes given
24Badges
227Days visited
4.6kPosts read

Most-liked posts

  • Second pass at: Regression to the mean in progress reports Replied, post #68 · Research Methods › Statistics · 26 Feb 2025 · 33 likes This follows post #65 rather than contradicting it. Confounding: a third variable explains an apparent association. In randomised data, randomisation balances…
  • Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 11 Mar 2025 · 31 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
  • Requesting a translation of an existing page Replied, post #4 · Documentation › Wiki requests · 24 Mar 2025 · 30 likes post #3 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
  • Tracking a shortage from primary sources rather than rumour Replied, post #7 · Access › Shortages · 12 May 2026 · 28 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
  • The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #87 · Compounds › Tirzepatide · 18 Apr 2026 · 28 likes On post #83 — agreed on the reasoning, with one qualification. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index,…
  • Where the four-week escalation interval comes from, and what it is not Replied, post #11 · Practice › Dosing & titration · 1 Jun 2024 · 28 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…

Where this member posts

CategoryPostsShare
Practice1416%
Compounds1112%
Evidence1011%
Analytics910%
Sourcing78%
Clinical67%

Badges earned, in order

BadgeTierGranted
Welcomebronze16 Nov 2024
Basic Userbronze17 Nov 2024
First Replybronze18 Nov 2024
Read the Guidelinesbronze18 Nov 2024
First Topicbronze19 Nov 2024
First Linkbronze2 Dec 2024
First Tagbronze10 Dec 2024
First Quotebronze16 Dec 2024
Memberbronze18 Dec 2024
Asked Wellbronze22 Dec 2024
Editorbronze1 Jan 2025
Generousbronze11 Jan 2025
Readerbronze15 Jan 2025
Good Postsilver9 Feb 2025
Sourcedbronze19 Mar 2025
Thank Yousilver12 Apr 2025
Nice Postbronze24 Apr 2025
First Vendor Reportbronze1 May 2025
Consistently Generoussilver20 May 2025
Welcomingsilver24 May 2025
Nice Topicbronze31 May 2025
Gives Backgold28 Jun 2025
Anniversarysilver14 Nov 2025
De-escalatorgold25 Mar 2026